| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |